Association of programmed cell death-1 gene polymorphisms with chronic hepatitis C virus infection and antiviral effect
-
摘要: 目的探明程序性细胞死亡受体1(PD-1)基因单核苷酸多态性(SNP)与慢性HCV感染及IFN联合利巴韦林抗HCV疗效的关系。方法选择2010年10月-2012年10月在河北省7家医院住院的慢性丙型肝炎(CHC)患者228例,采用IFN联合利巴韦林个体化方案进行抗病毒治疗,健康体检者81例作为对照组。Taq Man探针法检测PD-1基因多态性,分析患者及对照组PD-1.1及PD-1.3位点等位基因及基因型分布差异,并分析PD-1.1及PD-1.3位点SNP与抗HCV疗效的关系。计数资料组间比较采用χ2检验。结果 CHC患者组PD-1.1位点T等位基因、TT基因型携带率显著高于对照组(52.41%vs 43.21%,χ2=4.059,P=0.044;28.51%vs 14.81%,χ2=6.469,P=0.039);PD-1.1位点等位基因型分布在是否获得完全早期病毒学应答、是否获得持续病毒学应答的患者间差异均无统计学意义(P值均>0.05)。PD-1.3位点在CHC患者及对照组均为CC型。结论 PD-1.1位点T等位...
-
关键词:
- 肝炎,丙型,慢性 /
- 多态性,单核苷酸 /
- 程序性细胞死亡受体1
Abstract: Objective To investigate the association of single nucleotide polymorphisms( SNPs) of programmed cell death- 1( PD- 1)gene with chronic hepatitis C virus( HCV) infection and the effect of antiviral therapy with interferon combined with ribavirin. Methods A total of 228 patients with chronic hepatitis C( CHC) who were hospitalized in seven hospitals in Hebei Province,China from October 2010 to October 2012 were enrolled and treated with interferon combined with ribavirin as the individualized antiviral therapy. Eighty- one persons who underwent physical examination were enrolled as control group. The Taq Man probe method was used to detect PD- 1 gene polymorphisms. The distribution of alleles and genotypes at PD- 1. 1 and PD- 1. 3 were compared between the two groups,and the association between the SNPs of PD- 1. 1 and PD- 1. 3 and anti- HCV effect was analyzed. The chi- square test was used for the comparison of categorical data between groups. Results The CHC group showed significantly higher frequencies of T allele and TT genotype at PD- 1. 1 than the control group( 52. 41% vs 43. 21%,χ2= 4. 059,P = 0. 044; 28. 51% vs 14. 81%,χ2= 6. 469,P = 0. 039). The SNPs of PD- 1. 1 gene were not significantly associated with complete early virologic response or sustained virologic response( both P > 0. 05). Both groups had CC genotype at PD- 1. 3. Conclusion PD- 1. 1 T allele might be associated with chronic HCV infection,and patients carrying TT genotype have a high risk of chronic HCV infection. PD- 1. 1 polymorphism is not associated with virologic response to anti- HCV therapy. -
[1]LAVANCHY D.The global burden of hepatitis C[J].Liver Int,2009,29(Suppl 1):74-81. [2]FAWZY MM,WAHID A,NAZMY MH,et al.Association of interleukin-27 rs 153109 single nucleotide polymorphism with spontaneous resolution of hepatitis C virus-genotype 4a infection in egyptian patients[J].Asian Pac J Cancer Prev,2016,17(4):2093-2097. [3]YANG Y,LIU H.Association between interleukin-18 gene promoter(-607C/A and-137G/C)polymorphisms and chronic hepatitis C virus infections:a meta-analysis[J].Meta Gene,2015,5:21-31. [4]NADIA K,HICHAM E,REDA TM,et al.The complete title:The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C[J].Gene,2015,568(1):31-34. [5]KAWAOKA T,HAYES CN,OHISHI W,et al.Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b[J].J Hepatol,2011,54(3):408-414. [6]LIU C,JIANG J,GAO L,et al.A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China[J].Int J Genomics,2014,2014:247637. [7]MAHMOUDI M,REZAIEMANESH A,SALMANINEJAD A,et al.PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus[J].Autoimmunity,2015,48(7):488-493. [8]ZHANG G,LI N,ZHANG P,et al.PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated regionpolymorphism in patients with chronic HBV infection[J].Immunol Lett,2014,162(1 Pt A):212-216. [9]SU SS,HE H,KONG LB,et al.Regulatory phenotype,PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy:a randomized clinical trial[J].PLo S One,2014,9(4):e93620. [10]URBANI S,AMADEI B,TILA D,et al.Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection:effect of viremia levels and antiviral treatment[J].J Hepatol,2008,48(4):548-558. [11]NAKAMOTO N,KAPLAN DE,COLECLOUGH J,et al.Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization[J].Gastroenterology,2008,134(7):1927-1937. [12]XIAO W,JIANG LF,DENG XZ,et al.PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection[J].Immunol Res,2016,64(2):412-423. [13]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol,2015,31(12):1961-1979.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979. [14]ZHANG DD,YE PY,HUANG YX,et al.Analysis of predictive factors for rapid virologic response in treating patients with chronic hepatitis C[J].J Clin Hepatol,2014,30(12):1310-1314.(in Chinese)张丹丹,叶佩燕,黄玉仙,等.慢性丙型肝炎患者获得快速病毒学应答的预测因素分析[J].临床肝胆病杂志,2014,30(12):1310-1314. [15]VIDAL-CASTINEIRA JR,LOPEZ-VAZQUEZ A,ALONSOARIAS R,et al.A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping[J].J Hepatol,2012,56(6):1230-1238.
本文二维码
计量
- 文章访问数: 2098
- HTML全文浏览量: 20
- PDF下载量: 451
- 被引次数: 0